AAAAAA

   
Results: 1-9 |
Results: 9
PROGNOSTIC FEATURES OF ASYMPTOMATIC MULTIPLE-MYELOMA
Authors: WEBER DM DIMOPOULOS MA MOULOPOULOS LA DELASALLE KB SMITH T ALEXANIAN R
Citation: Dm. Weber et al., PROGNOSTIC FEATURES OF ASYMPTOMATIC MULTIPLE-MYELOMA, British Journal of Haematology, 97(4), 1997, pp. 810-814
HYPERCVAD FOR VAD-RESISTANT MULTIPLE-MYELOMA
Authors: DIMOPOULOS MA WEBER D KANTARJIAN H DELASALLE KB ALEXANIAN R
Citation: Ma. Dimopoulos et al., HYPERCVAD FOR VAD-RESISTANT MULTIPLE-MYELOMA, American journal of hematology, 52(2), 1996, pp. 77-81
PROGNOSTIC FEATURES OF ASYMPTOMATIC MULTIPLE-MYELOMA
Authors: WEBER DM DIMOPOULOS MA MOULOPOULOS LA DELASALLE KB SMITH TL ALEXANIAN R
Citation: Dm. Weber et al., PROGNOSTIC FEATURES OF ASYMPTOMATIC MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 1548-1548
MYELOABLATIVE THERAPY FOR PRIMARY RESISTANT MULTIPLE-MYELOMA
Authors: ALEXANIAN R DIMOPOULOS MA DELASALLE KB HESTER J CHAMPLIN R
Citation: R. Alexanian et al., MYELOABLATIVE THERAPY FOR PRIMARY RESISTANT MULTIPLE-MYELOMA, Stem cells, 13, 1995, pp. 118-121
TREATMENT OF WALDENSTROMS MACROGLOBULINEMIA RESISTANT TO STANDARD THERAPY WITH 2-CHLORODEOXYADENOSINE - IDENTIFICATION OF PROGNOSTIC FACTORS
Authors: DIMOPOULOS MA WEBER D DELASALLE KB KEATING M ALEXANIAN R
Citation: Ma. Dimopoulos et al., TREATMENT OF WALDENSTROMS MACROGLOBULINEMIA RESISTANT TO STANDARD THERAPY WITH 2-CHLORODEOXYADENOSINE - IDENTIFICATION OF PROGNOSTIC FACTORS, Annals of oncology, 6(1), 1995, pp. 49-52
PROGNOSTIC-SIGNIFICANCE OF MAGNETIC-RESONANCE-IMAGING IN PATIENTS WITH ASYMPTOMATIC MULTIPLE-MYELOMA
Authors: MOULOPOULOS LA DIMOPOULOS MA SMITH TL WEBER DM DELASALLE KB LIBSHITZ HI ALEXANIAN R
Citation: La. Moulopoulos et al., PROGNOSTIC-SIGNIFICANCE OF MAGNETIC-RESONANCE-IMAGING IN PATIENTS WITH ASYMPTOMATIC MULTIPLE-MYELOMA, Journal of clinical oncology, 13(1), 1995, pp. 251-256
PRIMARY PLASMA-CELL LEUKEMIA
Authors: DIMOPOULOS MA PALUMBO A DELASALLE KB ALEXANIAN R
Citation: Ma. Dimopoulos et al., PRIMARY PLASMA-CELL LEUKEMIA, British Journal of Haematology, 88(4), 1994, pp. 754-759
COMBINATION THERAPY WITH INTERFERON-DEXAMETHASONE FOR NEWLY-DIAGNOSEDPATIENTS WITH MULTIPLE-MYELOMA
Authors: DIMOPOULOS MA WEBER D DELASALLE KB ALEXANIAN R
Citation: Ma. Dimopoulos et al., COMBINATION THERAPY WITH INTERFERON-DEXAMETHASONE FOR NEWLY-DIAGNOSEDPATIENTS WITH MULTIPLE-MYELOMA, Cancer, 72(9), 1993, pp. 2589-2592
THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE - A NEW PREPARATIVE REGIMEN FOR AUTOLOGOUS MARROW OR BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MULTIPLE-MYELOMA
Authors: DIMOPOULOS MA ALEXANIAN R PRZEPIORKA D HESTER J ANDERSSON B GIRALT S MEHRA R VANBESIEN K DELASALLE KB READING C DEISSEROTH AB CHAMPLIN RE
Citation: Ma. Dimopoulos et al., THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE - A NEW PREPARATIVE REGIMEN FOR AUTOLOGOUS MARROW OR BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MULTIPLE-MYELOMA, Blood, 82(8), 1993, pp. 2324-2328
Risultati: 1-9 |